Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain.

Source:http://linkedlifedata.com/resource/pubmed/id/12007754

Download in:

View as

General Info

PMID
12007754